Source: Lew Rockwell | VIEW ORIGINAL POST ==>
Lew,
It won’t be easy at this point for Bill Gates and the depopulation globalists to roll out another plandemic to inject Americans with an experimental mRNA shot. Prior to the Covid con, few Americans questioned the safety and efficacy of vaccines, but now most don’t trust mRNA shots. The new strategy of the globalists is to get the toxin mRNA into the population by injecting the food supply with these jabs.
I asked Grok3, the AI tool now being beta tested on X, if President Trump has authorized the vaccination of chickens to fight bird flu. The answer is his administration has a plan toward vaccinating poultry against avian flu and the USDA granted conditional approval to a drug company to inject poultry for avian flu.
Grok’s response:
As of February 22, 2025, there is no definitive evidence that President Donald Trump has formally agreed to vaccinate chickens for avian flu. However, recent developments suggest that his administration is actively exploring this option as part of a broader strategy to combat the ongoing avian influenza outbreak and address soaring egg prices.
The Trump administration has signaled a shift away from the previous U.S. policy of culling entire flocks to control avian flu outbreaks, a practice that has led to the destruction of over 150 million birds since 2022 and contributed to record-high egg prices. Kevin Hassett, Director of the National Economic Council, indicated on CBS’s “Face the Nation” on February 16, 2025, that the administration is working on a plan that emphasizes “biosecurity and medication” rather than mass depopulation. While “medication” could imply vaccination, Hassett did not explicitly confirm it, instead focusing on developing a “smart perimeter” to manage outbreaks more effectively. He noted collaboration with Agriculture Secretary Brooke Rollins and leading scientists to finalize this approach, with further details expected soon.
A significant step toward vaccination occurred on February 14, 2025, when the U.S. Department of Agriculture (USDA) granted conditional approval to Zoetis, an animal healthcare company, to use its avian flu vaccine in poultry. This marks a potential policy shift, as the U.S. has historically avoided vaccinating chickens due to trade restrictions—many countries do not accept vaccinated poultry exports—and challenges in detecting the virus in vaccinated birds. Zoetis emphasized that the decision to vaccinate commercial flocks rests with federal authorities in consultation with the poultry industry, suggesting that any final approval would require Trump administration endorsement.
Reports from various sources indicate that Trump’s team is considering vaccination as a tool to reduce economic fallout from the outbreak, which has driven egg prices to an average of $4.15 per dozen in December 2024, with a projected 20% increase in 2025. The Washington Examiner noted that allowing farmers to vaccinate could be a cost-effective solution, contrasting this with the Biden administration’s reluctance, attributed to trade and market concerns despite USDA tests in 2023 showing vaccine efficacy. Meanwhile, posts on X reflect public speculation, with some claiming Trump has already greenlit mRNA vaccines for chickens, though no official statement or documentation confirms this as of now.
Agriculture Secretary Brooke Rollins, in a Breitbart interview, acknowledged vaccination as an option under review but highlighted potential trade disruptions, indicating the administration is weighing multiple factors. The Associated Press reported on February 18, 2025, that the new strategy would stress “vaccinations and tighter biosecurity,” further suggesting momentum toward this approach, though no final commitment was detailed.
In summary, while President Trump has not explicitly agreed to vaccinate chickens for avian flu as of the latest available information, his administration is actively developing a plan that appears to lean toward incorporating vaccines, supported by the USDA’s conditional approval to Zoetis. An official announcement or policy decision would be needed to confirm this direction, and none has been reported by February 22, 2025. Given the administration’s focus on reducing egg prices and its criticism of prior culling practices, vaccination remains a likely component of its emerging strategy.
